Business Context and Reporting Period
On July 28, 2026, CBIZ, Inc. (CBZ) filed a Form 8-K to report the entry into a definitive Agreement and Plan of Merger with Viking ParentCo, Inc. ("Parent"). Under the agreement, Viking MergerCo, Inc. will merge with and into CBIZ, with CBIZ surviving as a wholly-owned subsidiary of Parent. The Board of Directors has unanimously approved the transaction and recommended it to stockholders.
Key Financial Metrics and Transaction Terms
- Merger Consideration: $55.00 per share in cash for all outstanding shares of CBIZ common stock (excluding treasury stock, shares owned by Parent/Merger Sub, and shares held by dissenting stockholders).
- Financing: Parent has secured aggregate financing commitments of $5.2 billion from New Mountain Partners VII, L.P., New Mountain Partners VII Luxembourg, SCSp, and other third-party sources to fund the transaction.
- Termination Fees:
- Company Termination Fee: $107,500,000 payable by CBIZ to Parent under specific conditions (e.g., superior proposal, change in recommendation). This fee is reduced to $49,600,000 if terminated during the "Go-Shop Period" or for an "Excluded Party" proposal.
- Parent Termination Fee: $198,400,000 payable by Parent to CBIZ if Parent fails to consummate the merger due to breach or failure to close, or if Parent terminates due to the expiration of the termination date.
- Equity Award Treatment: Vested options, RSUs, and performance shares will be cashed out at the merger consideration. Unvested awards generally convert to replacement awards or assumed units that vest based on continued employment or specific termination events.
Material Changes and Agreements
The filing details the execution of the Merger Agreement, which includes a "Go-Shop Period" ending at 11:59 p.m. Eastern Time on August 27, 2026. During this period, CBIZ may solicit alternative acquisition proposals. Following this period, CBIZ is subject to "no-shop" restrictions, with limited exceptions for superior proposals received during the Go-Shop Period. The transaction is subject to customary closing conditions, including stockholder approval, antitrust clearance (Hart-Scott-Rodino), and the absence of a Material Adverse Effect.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance or operating outlook for CBIZ as an independent entity, as the company is now in a definitive merger process. Management commentary is limited to the Board's determination that the transaction is fair and in the best interests of stockholders.
Risks and Contingencies:
- Failure to satisfy closing conditions, including regulatory approvals or stockholder vote.
- Disruption of ongoing business operations and management focus due to the transaction.
- Uncertainty regarding the ability to retain key personnel and customers.
- Potential for shareholder litigation or other legal challenges.
- Failure to realize anticipated synergies or benefits of the combined company.
Executive Compensation and Severance
In connection with the merger, the Board adopted a Change in Control Severance Plan ("CIC Severance Plan") and transaction/retention bonus programs.
- Severance: Eligible employees, including Named Executive Officers (NEOs), may receive cash payments ranging from 0.5x to 3x annual compensation (CEO eligible for 3x; other NEOs for 2x) plus prorated bonuses and health coverage upon termination without Cause or resignation for Good Reason within two years of the change in control.
- Transaction Bonuses: NEOs are eligible for immediate transaction bonuses: Jerome P. Grisko, Jr. ($1,302,000), Brad Lakhia ($812,000), and Michael Kouzelos ($486,000).
- Retention Bonuses: 25% payable upon consummation of the change in control and 75% payable six months post-consummation, subject to continued employment.
Investor Verification Checklist
- Verify the final vote count and approval status of the Merger Agreement by CBIZ stockholders.
- Monitor the status of regulatory approvals, specifically the expiration of the Hart-Scott-Rodino waiting period.
- Review the definitive Proxy Statement (Schedule 14A) for detailed financial analysis, risk factors, and voting instructions.
- Confirm the final terms of the $5.2 billion financing commitment and any conditions precedent to funding.
- Track any alternative acquisition proposals received during the Go-Shop Period (through August 27, 2026).